The immunomodulatory ability of the mycobacterial hsp65 in autoimmune diseases has been demonstrated by us and other authors in arthritis [28, 29], diabetes [30–32], and atherosclerosis [27, 33]. The gene discussed is HSPD1; the disease is autoimmune disease.